School of Medicine


Showing 11-20 of 75 Results

  • Maximilian Diehn, MD, PhD

    Maximilian Diehn, MD, PhD

    Jack, Lulu, and Sam Willson Professor and Professor of Radiation Oncology (Radiation Therapy)

    Current Research and Scholarly InterestsMy laboratory focuses on two main areas: 1) cancer stem cell biology and 2) novel biomarkers for identifying the presence of malignant cells (diagnostic), predicting outcome (prognostic), and predicting response to therapy (predictive). Areas of study include cancers of the lung, breast, and gastrointestinal system. Clinically I specialize in the treatment of lung cancer and applications of stereotactic ablative radiotherapy and perform both prospective and retrospective clinical studies.

  • Sarah S. Donaldson, MD

    Sarah S. Donaldson, MD

    Catharine and Howard Avery Professor in the School of Medicine, Emerita

    Current Research and Scholarly InterestsCombined Modality Treatment of Cancer
    Late Effects of Treatment
    Genetic Effects of Cancer
    Rhabdomyosarcoma
    Hodgkins Disease
    Pediatric Radiation Oncolgy
    Pediatric Oncolgy
    Breast Cancer
    Conformal Radiotherapy/IMRT
    Radiotherapy for Benign Diseases

  • Michael Louis Dworkin

    Michael Louis Dworkin

    Affiliate, Dean's Office Operations - Dean Other
    Resident in Radiation Oncology - Radiation Therapy

    BioDr. Dworkin graduated from The Ohio State University in 2012, where he studied mathematics and was inducted into Phi Beta Kappa. There, he developed a research interest in systems biology and oncology and won a Pelotonia Undergraduate Cancer Research Fellowship. He received his MD from Duke University School of Medicine in 2018. During medical school, he developed an interest in radiation oncology and researched psuedoprogression in patients with low-grade gliomas treated with proton radiotherapy. He completed a preliminary internal medicine internship at University of Kentucky in 2019. Currently, he is a resident physician in the Department of Radiation Oncology at Stanford. His work at Stanford has led to several abstracts and a first-authored publication on the use of a radiotherapy boost in patients undergoing hematopoietic stem cell transplant. He is interested in a career in academic radiation oncology focused on the development and implementation of radiobiologically informed and innovative radiotherapy treatment approaches and technologies that aim to deliver effective treatment while minimizing burden to patients with cancer.

  • Alireza Ghiam, MD, MS

    Alireza Ghiam, MD, MS

    Clinical Associate Professor, Radiation Oncology - Radiation Therapy

    BioDr. Ghiam is a board-certified radiation oncologist with the Stanford Medicine Cancer Center and a Clinical Associate Professor in the Department of Radiation Oncology at Stanford University School of Medicine. Dr. Ghiam completed his residency in radiation oncology and fellowship in head & neck and genitourinary radiation oncology at the University of Toronto.

    He diagnoses and treats various conditions specializing in head & neck cancer, genitourinary malignancies, and metastatic disease. His treatment expertise includes oligometastatic disease, palliative radiation oncology, stereotactic ablative radiotherapy, and proton therapy.

    Dr. Ghiam's research interest lies in conducting clinical trials of innovative radiation therapy techniques with a focus on leveraging technology and biology to reduce toxicity and increase precision. He is also interested in exploring novel AI-powered technologies that can enhance patient outcomes, and bridge health equity gaps in radiation oncology.

    Dr. Ghiam has contributed to the field through his authorship of technology- and biology-based publications and collaboration in clinical trials. He has been recognized for his work in both academic and private practice, receiving awards from the American Society for Radiation Oncology (ASTRO), the Canadian Association of Radiation Oncology (CARO), and the Universities of Toronto and Pennsylvania.

    He is committed to improving patient outcomes and changing the role of supportive care in radiation oncology by promoting quality standards and utilizing palliative radiotherapy to enhance the quality of life for his patients.

    Dr. Ghiam is a devoted academic who places great emphasis on education and diversity. He is committed to providing compassionate, evidence-based care and treats his patients as if they were family.

  • Michael Gensheimer

    Michael Gensheimer

    Clinical Associate Professor, Radiation Oncology - Radiation Therapy

    Current Research and Scholarly InterestsIn addition to my clinical research in head and neck and lung cancer, I work on the application of computer science and machine learning to cancer research. I develop tools for analyzing large datasets to improve outcomes and safety of cancer treatment. I developed a machine learning prognostic model using data from around 13,000 patients with metastatic cancer which performs better than traditional models and physicians [PubMed ID 33313792]. We recently completed a prospective randomized study in thousands of patients in which the model was used to help improve advance care planning conversations.

    I also work on the methods underpinning observational and predictive modeling research. My open source nnet-survival software that allows use of neural networks for survival modeling has been used by researchers internationally. In collaboration with the Stanford Research Informatics Center, I examined how electronic medical record (EMR) survival outcome data compares to gold-standard data from a cancer registry [PubMed ID 35802836]. The EMR data captured less than 50% of deaths, a finding that affects many studies being published that use EMR outcomes data.

  • Iris C. Gibbs, MD, FACR, FASTRO

    Iris C. Gibbs, MD, FACR, FASTRO

    Professor of Radiation Oncology (Radiation Therapy) and, by courtesy, of Neurosurgery

    Current Research and Scholarly InterestsDr. Gibbs is a board-certified radiation oncologist who specializes in the treatment of CNS tumors. Her research focuses on developing new radiation techniques to manage brain and spinal tumors in adults and children. Dr. Gibbs has gained worldwide acclaim for her expertise in Cyberknife robotic radiosurgery.